Ricevi le ultime notizie sulle azioni MiNK Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di INKT

Ultime notizie per

MINK THERAPEUTICS INC

MiNK Therapeutics

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

MiNK Therapeutics Inc

Press Releases

MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

Earnings

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress

News

Financing

General

MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

Health Care

MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer

MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy

MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results

INKT

Adicet Bio

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Aligos Therapeutics

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Annovis Bio

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Cue Biopharma

CEL-SCI

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Gain Therapeutics

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

ImmuCell

InflaRx

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kala Bio

MAIA Biotechnology

MediciNova

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Renovaro

Serina Therapeutics

Shattuck Labs

Unicycive Therapeutics, Inc. - Common Stock

Comments

MiNK Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO